Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement
Fifty 1 Labs and All-In-Extracts have entered a joint venture to develop a new testosterone-boosting supplement. Combining Fifty 1 Labs' supplement expertise and All-In-Extracts' advanced botanical extraction methods, they aim to create a product that supports natural testosterone production and overall well-being.
Clinical trials will begin promptly to ensure safety, efficacy, and quality, with the product expected to launch in Q4 2024 initially in the U.S., followed by international expansion. The supplement targets common issues such as low energy and reduced muscle mass and is intended for both men and women.
Both companies emphasize transparency, safety, and quality, with plans for an extensive marketing campaign to educate consumers.
Fifty 1 Labs e All-In-Extracts hanno avviato una joint venture per sviluppare un nuovo integratore alimentare per il potenziamento del testosterone. Combinando l'expertise di Fifty 1 Labs negli integratori e i metodi avanzati di estrazione botanica di All-In-Extracts, mirano a creare un prodotto che supporti la produzione naturale di testosterone e il benessere generale.
Le prove cliniche inizieranno prontamente per garantire sicurezza, efficacia e qualità, con il prodotto previsto per il lancio nel quarto trimestre del 2024 inizialmente negli Stati Uniti, seguito da un'espansione internazionale. L'integratore punta a problemi comuni come la bassa energia e la riduzione della massa muscolare ed è destinato sia agli uomini che alle donne.
Entrambe le aziende sottolineano l'importanza della trasparenza, della sicurezza e della qualità, con piani per una vasta campagna di marketing per educare i consumatori.
Fifty 1 Labs y All-In-Extracts han formado una empresa conjunta para desarrollar un nuevo suplemento que aumente los niveles de testosterona. Combinando la experiencia de Fifty 1 Labs en suplementos y los avanzados métodos de extracción botánica de All-In-Extracts, su objetivo es crear un producto que apoye la producción natural de testosterona y el bienestar general.
Los ensayos clínicos comenzarán de inmediato para garantizar la seguridad, la eficacia y la calidad, con la expectativa de que el producto se lance en el cuarto trimestre de 2024, inicialmente en EE. UU. y luego en expansión internacional. El suplemento está dirigido a problemas comunes como la baja energía y la reducción de la masa muscular, y está destinado tanto a hombres como a mujeres.
Ambas empresas enfatizan la transparencia, la seguridad y la calidad, y tienen planes para una amplia campaña de marketing para educar a los consumidores.
Fifty 1 Labs와 All-In-Extracts가 새로운 테스토스테론 증진 보충제를 개발하기 위해 합작 회사를 설립했습니다. Fifty 1 Labs의 보충제 전문성과 All-In-Extracts의 고급 식물 추출 방법을 결합하여 자연적인 테스토스테론 생산과 전반적인 웰빙을 지원하는 제품을 만들고자 합니다.
안전성, 효능 및 품질을 보장하기 위해 임상시험이 즉시 시작될 예정이며, 제품은 2024년 4분기에 미국에서 처음 출시되고, 그 후 국제적으로 확장될 계획입니다. 이 보충제는 낮은 에너지와 감소된 근육량과 같은 일반적인 문제를 대상으로 하며 남성과 여성 모두를 위한 것입니다.
양사는 투명성, 안전성 및 품질을 강조하며 소비자를 교육하기 위한 광범위한 마케팅 캠페인을 계획하고 있습니다.
Fifty 1 Labs et All-In-Extracts ont créé une coentreprise pour développer un nouveau complément alimentaire stimulant la testostérone. En combinant l'expertise de Fifty 1 Labs dans les compléments et les méthodes avancées d'extraction botanique d'All-In-Extracts, elles visent à créer un produit qui soutient la production naturelle de testostérone et le bien-être général.
Les essais cliniques commenceront rapidement pour garantir la sécurité, l'efficacité et la qualité, avec un lancement du produit prévu pour le quatrième trimestre 2024, initialement aux États-Unis, suivi d'une expansion internationale. Le complément vise des problèmes courants comme la faible énergie et la réduction de la masse musculaire et est destiné aussi bien aux hommes qu'aux femmes.
Les deux entreprises mettent l'accent sur la transparence, la sécurité et la qualité, avec des projets pour une vaste campagne marketing visant à éduquer les consommateurs.
Fifty 1 Labs und All-In-Extracts haben ein Joint Venture gegründet, um ein neues Testosteron-steigerndes Ergänzungsmittel zu entwickeln. Durch die Kombination der Ergänzungskompetenz von Fifty 1 Labs und den fortschrittlichen botanischen Extraktionsmethoden von All-In-Extracts zielt man darauf ab, ein Produkt zu schaffen, das die natürliche Testosteronproduktion und das allgemeine Wohlbefinden unterstützt.
Klinische Studien werden umgehend beginnen, um Sicherheit, Wirksamkeit und Qualität zu gewährleisten, wobei der Produktlaunch im vierten Quartal 2024 zunächst in den USA und anschließend international erwartet wird. Das Ergänzungsmittel zielt auf häufige Probleme wie geringe Energie und reduzierte Muskelmasse ab und ist sowohl für Männer als auch für Frauen gedacht.
Beide Unternehmen betonen Transparenz, Sicherheit und Qualität und planen eine umfangreiche Marketingkampagne, um die Verbraucher zu informieren.
- Joint venture with Fifty 1 Labs and All-In-Extracts combines expertise in supplement formulation and botanical extraction.
- Clinical trials set to begin promptly to ensure product safety and efficacy.
- Expected market release of the testosterone-boosting supplement in Q4 2024.
- Product targets common issues like low energy, reduced muscle mass, and diminished libido.
- Extensive marketing campaign planned to educate consumers.
- Pending clinical trials could delay product release if results are inconclusive.
This joint venture combines the scientific research and advanced extraction techniques from both companies to create a product aimed at supporting natural testosterone production and enhancing overall well-being for men and women.
Fifty 1 Labs' expertise in supplement formulation and All-In-Extracts' superior botanical extraction methods will be combined to develop a high-quality, effective product. The synergy between these two industry leaders promises a product that is both scientifically robust and naturally potent.
The testosterone-boosting supplement will feature a unique blend of natural ingredients known for their potential to enhance testosterone levels and promote vitality. These ingredients have been carefully selected based on extensive research and clinical evidence supporting their efficacy.
Clinical trials are set to begin promptly to ensure the safety, efficacy, and quality of the product. These trials will be conducted under rigorous scientific protocols, with results expected to guide the final formulation and dosage. This step underscores the commitment of both companies to delivering a product that consumers can trust.
The new testosterone-boosting supplement aims to address common issues faced by men and women, such as low energy levels, reduced muscle mass, and diminished libido. By supporting natural testosterone production, the product is expected to improve overall health and vitality, helping men and women to achieve a better quality of life.
Pending successful clinical trials, the new product is slated for market release in Q4 2024, with an initial launch in
"We are thrilled to collaborate with All-In-Extracts on this innovative project," said Robert Clark, CEO of Fifty 1 Labs, Inc. "Starting clinical trials promptly demonstrates our commitment to bringing a safe, effective, and high-quality product to the market. This joint venture allows us to leverage our combined expertise and resources to create something truly remarkable."
Matthew Grisham, CEO of All-In-Extracts, added, "This joint venture reflects our shared dedication to natural wellness and scientific excellence. We are confident that our combined efforts will result in a product that will significantly benefit the health of men and women. Our commitment to quality and transparency ensures that consumers can trust our product to deliver real results."
The testosterone-boosting supplement aims to meet the needs of men and women seeking to improve their energy, performance, and overall health through natural means. Both companies are dedicated to transparency, safety, and customer satisfaction, ensuring that the new product will meet the highest standards.
About Fifty 1 Labs, Inc. Fifty 1 Labs, Inc. (Ticker symbol: CAFI), a publicly traded entity, is currently undergoing a name and symbol transition to become Fifty 1 Labs, Inc. This transformation is accompanied by the company's ownership of three distinct subsidiaries entrenched within the domains of sports supplementation, fitness apparatus, and holistic well-being. These subsidiaries include 51, LLC, a pioneer in the development of innovative health and wellness supplements. With a focus on science-backed formulations and premium ingredients, 51 Labs is committed to helping individuals achieve optimal health and well-being. The company's portfolio includes a range of products designed to address various health concerns, from cognitive function to physical performance: The Quickness, the proud holder of a patent for pioneering athletic training equipment meticulously crafted to enhance linebacker development; Drago Knives, LLC, a cutting edge knife throwing company with a patented style of throwing knives; and Astound NMN, a beacon of excellence within the anti-aging sector, heralding the era of DNA reparation through its premium supplements. Guided by an unwavering commitment, Fifty 1 Labs, Inc. remains at the forefront of innovation, consistently presenting avant-garde solutions infused with state-of-the-art technology, poised to empower individuals in their pursuit of fitness and holistic health aspirations. Additionally, Fifty 1 Labs, Inc. remains actively engaged in pursuing strategic acquisitions aimed at fortifying its portfolio by incorporating profit-generating enterprises into its fold.
About All-In-Extracts All-In-Extracts, a wholly owned subsidiary of Royal Biotek Enterprises (Ticker Symbol: BLEG) is a leading provider of high-quality botanical extracts. Utilizing cutting-edge extraction methods and rigorous quality control processes, All-In-Extracts delivers potent and pure extracts that serve as the foundation for numerous health and wellness products. The company's dedication to sustainability and ethical sourcing ensures that their products are not only effective but also environmentally responsible.
Media Contacts:
Fifty 1 Labs, Inc.
Jonathan Werlang
Vice President
Email: ir@fifty1labs.com Phone: (877) 814-4188
All-In-Extracts
Matthew Grisham
CEO
Email: info@starhillhemp.com Phone: (987) 654-3210
For further information, please visit Fifty 1 Labs' website or All-In-Extracts' website.
For further information, please contact: Jonathan Werlang (877) 814-4188
Safe Harbor Statement: The information provided in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Identifiable by words such as "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions, these statements may also be made in written or oral form in the company's filings with the
View original content:https://www.prnewswire.com/news-releases/fifty-1-labs-inc-and-all-in-extracts-announce-joint-venture-to-develop-and-release-new-testosterone-boosting-supplement-302214320.html
SOURCE Fifty 1 Labs, Inc.
FAQ
What is the new product developed by All-In-Extracts and Fifty 1 Labs?
When will the new testosterone supplement be released?
What are the benefits of the new testosterone supplement by Fifty 1 Labs and All-In-Extracts?
What will the clinical trials for the new testosterone supplement focus on?
Which companies are involved in the joint venture for the testosterone supplement?
